NCT03493204 is a NA clinical trial of Meal delivery in Hepatic Encephalopathy, sponsored by University of Michigan.

Who is sponsoring NCT03493204?

NCT03493204 is sponsored by University of Michigan.

What drugs are being tested in NCT03493204?

Interventions in NCT03493204: Meal delivery, Standard pamphlet with Dietary Advice.

What condition does NCT03493204 study?

NCT03493204 studies Hepatic Encephalopathy, Ascites, Liver Diseases, Cirrhosis.

Is NCT03493204 still recruiting?

NCT03493204 is currently completed. Last updated 30 August 2019.

Last reviewed 2019-08-30 · How we verify

NCT03493204

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD Trial

Completed NA Last updated 30 August 2019

What this trial tests

NA trial testing Meal delivery in Hepatic Encephalopathy in 44 participants. Completed in 19 August 2019.

Timeline

24 April 2018

Primary endpoint
19 August 2019

19 August 2019

Quick facts

Lead sponsor	University of Michigan
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	44
Start date	24 April 2018
Primary completion	19 August 2019
Estimated completion	19 August 2019
Sites	1 location across United States

Drugs / interventions tested

Meal delivery
Standard pamphlet with Dietary Advice

Conditions studied

Hepatic Encephalopathy — all drugs for Hepatic Encephalopathy →
Ascites — all drugs for Ascites →
Liver Diseases — all drugs for Liver Diseases →
Cirrhosis — all drugs for Cirrhosis →

Sponsor

University of Michigan

Who can join

18 and older, any sex, with Hepatic Encephalopathy or Ascites. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the feasibility of a home meal delivery program for patients with cirrhosis and ascites and to determine the effectiveness of a salt-restricted (2 gram sodium) meal delivery program in reducing the need for therapeutic paracenteses and/or all-cause re-admissions for these patients. Many patients with cirrhosis don't have enough nutrients in the body and are frail and these meals may help them maintain a good diet and lead to improved quality of life.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Medically tailored meals for the management of symptomatic ascites: the SALTYFOOD pilot randomized clinical trial.
Tapper EB, Baki J, Nikirk S, Hummel S, et al · · 2020 · cited 19× · PMID 33442478 · DOI 10.1093/gastro/goaa059
Design and rationale of a randomized-controlled trial of home-delivered meals for the management of symptomatic ascites: the SALTYFOOD trial.
Tapper EB, Baki J, Hummel S, Lok A. · · 2019 · cited 4× · PMID 30976428 · DOI 10.1093/gastro/goz005

Verify or expand the search:

Other trials of Meal delivery

Trials testing the same drug.

NCT04810026 — Transform Type 2: Examining Meal-Delivery and Education for Diabetes Self-Care · NA · completed

Other recruiting trials for Hepatic Encephalopathy

Currently open trials in the same condition.

NCT07521332 — Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis · Phase 4 · recruiting
NCT07418008 — The Liver Cirrhosis Cognitive Decline Scale (LiCCoS) · recruiting
NCT06953921 — Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in · recruiting
NCT07437638 — Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liv · active not recruiting
NCT06425380 — Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy · NA · recruiting

Other University of Michigan trials

Trials by the same sponsor.

NCT07536919 — Integrating Care for Hypertension-Diabetes MULTImorbidity in Guatemala Through HEARTS Implementation · NA · not yet recruiting
NCT05509842 — Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD) · NA · not yet recruiting
NCT06311188 — Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness · NA · not yet recruiting
NCT07471646 — Effects of Ramadan Fasting With Exercise on Cardiometabolic Health · NA · not yet recruiting
NCT06671925 — A Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03493204 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Michigan
Last refreshed: 30 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03493204.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing